Bisphenol A (BPA),
a globally prevalent environmental contaminant,
has been shown to have the potential to disrupt intestinal barrier
function. This study explored the mechanisms of BPA-induced intestinal
barrier dysfunction. In addition, the protective effect of the natural
product icariin (ICA) on BPA-induced intestinal barrier dysfunction
was evaluated. BPA relieved oxidative stress (reactive oxygen species
(ROS), reactive nitrogen species (RNS), malondialdehyde (MDA), and
hydrogen peroxide (H
2
O
2
)), suppressed antioxidant
enzyme (superoxide dismutase (SOD), glutathione peroxidase (GPx),
catalase (CAT), and total antioxidant capacity (T-AOC)) activity,
and increased gene expression and protein content of p38 mitogen-activated
protein kinase (MAPK), giving rise to the dysfunctional gut in mice.
ICA therapy effectively eased intestinal barrier dysfunction caused
by BPA
in vivo
and
in vitro
. Treatment
with p38 MAPK inhibitor (SB203580) significantly rescued the MODE-K
cell barrier function disrupted by BPA challenge. However, treatment
with p38 MAPK activator (anisomycin) did not attenuate the MODE-K
cell barrier function impaired by BPA challenge. Overall, our data
suggested that BPA disrupted intestinal barrier function in a p38
MAPK-dependent manner. Furthermore, we demonstrated that ICA regulated
the redox equilibrium of intestinal epithelial cells by inhibiting
the expression of p38 MAPK, thereby alleviating BPA-induced disruption
of intestinal barrier function. These findings contributed to a better
understanding of the mechanisms of BPA-induced intestinal barrier
dysfunction and provided new insights into the prevention and treatment
of BPA-induced intestinal diseases.